RNAC
Cartesian Therapeutics (RNAC)
$76
About Cartesian Therapeutics (RNAC)
Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates. The company is headquartered in Gaithersburg, MD.
Details
Daily high
$6.83
Daily low
$6.41
Price at open
$6.41
52 Week High
$20.12
52 Week Low
$5.98
Market cap
175.8M
Dividend yield
0.00%
Volume
111,090
Avg. volume
236,428
P/E ratio
-.13
Cartesian Therapeutics News
Details
Daily high
$6.83
Daily low
$6.41
Price at open
$6.41
52 Week High
$20.12
52 Week Low
$5.98
Market cap
175.8M
Dividend yield
0.00%
Volume
111,090
Avg. volume
236,428
P/E ratio
-.13